Skip to main content
Register
Medicine Matters Diabetes
TOOLBAR 1 2 3 4
SEARCH
MENU 1 2 3 4
Close search form
main-content
Top
Print
​
print
​
share

09-20-2019 | Nephropathy | Video | Article

Expert commentary: The PRIORITY trial results

Luigi Gnudi discusses the findings of the PRIORITY trial and addresses whether diabetologists should consider intervening earlier in diabetic nephropathy (4:08)

Receive weekly updates on the diabetes news that matters to you

Register for the e-alert!


Read the interview transcript

Back to the EASD 2019 conference hub

Related topics

Anti-hypertensive medications rotated-square
Type 2 diabetes rotated-square

Related content

09-20-2019 | Nephropathy | EASD 2019 | News

Mixed results for PRIORITY diabetic nephropathy trial

06-13-2019 | Dapagliflozin | ADA 2019 | News

Dapagliflozin renoprotective in diabetes patients with preserved kidney function

04-15-2019 | Nephropathy | Highlight | News

Canagliflozin may offer renal protection in people with type 2 diabetes and CKD

07-29-2019 | Pathophysiology | News

Cluster analysis may help to predict diabetic complications

DiRECT: Type 2 diabetes remission through weight management

Primary findings, 2-year outcomes and translating this landmark trial into practice
Image Credits

Version: 0.1237.0